Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy Of Recombinant Human Deoxyribonuclease Eye Drops In Patients With Sjogren's and Non-Sjogren Dry Eye Disease

NCT02193490 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.

NCT NCT02193490
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02193490 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy Of Recombinant Human Deoxyribonuclease Eye Drops In Patients With Sjogren's and Non-Sjogren Dry Eye Disease
Lead sponsor
University of Illinois at Chicago
Phase
Phase 1/2
Overall status
Terminated
Start date
July 31, 2014
Completion date
October 11, 2017
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye